HC Wainwright & Co. Reiterates Buy on Entera Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Entera Bio (NASDAQ:ENTX) and maintained a $10 price target.
May 14, 2024 | 10:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Entera Bio's stock rating was reiterated as Buy by HC Wainwright & Co. with a maintained price target of $10.
The reiteration of a Buy rating and the maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. could positively influence investor sentiment towards ENTX, potentially driving short-term price movement upwards.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100